This will be a randomized, open-label, 3-way crossover design study to assess the drug-drug interaction between a single oral dose of ASP1941 and a single oral dose of Miglitol in healthy adult male volunteers. Each subject will receive ASP1941 alone, Miglitol alone and ASP1941 + Miglitol.
This study is to assess the pharmacokinetic interaction between ASP1941 and Miglitol in healthy volunteers.